Vital Specialized Biopharmaceutical Insights and Analytics

for Experts from Experts

BioTrends is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Featured Report
TreatmentTrends®: Multiple Myeloma

This bi-annual series of reports examines the current trends in the management of multiple myeloma from the perspective of hematologist-oncologists in the US.
Learn More

Coming soon in Q1

View our reports coming soon in Q1 on the following topics:

Search Published Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

Proprietary Question Deadlines

 Clients purchasing prior to fielding will have the opportunity to include up to three proprietary questions in each wave.

Responses to proprietary questions will be provided only to those sponsors and will not be included in the syndicated version but provided under separate cover.

 
 

Syndicated Report

Deadline

TreatmentTrends®: Glaucoma Feb. 3
TreatmentTrends®: Multiple Sclerosis US Feb. 6
LaunchTrends®: Krystexxa (Gout) US Feb. 6
PatientTrends®: Multiple Sclerosis US Feb. 21
TreatmentTrends®: Gout US Feb. 21
TreatmentTrends®: Epilepsy US Feb. 27
ChartTrends®: Multiple Sclerosis EU Feb. 28

 


 

Syndicated Publication Plan [ view all ]

  • TreatmentTrends® reports are now offered in 23 unique therapeutic/global markets
  • ChartTrends® reports are now offered in 18 unique therapeutic/global markets
  • LaunchTrends® reports are planned for products with anticipated approval dates
  • PatientTrends™ reports are offered in 7 unique therapeutic/global markets
  • Special Reports are offered in 3 unique therapeutic/global markets

2012 Publication Plan
2011 Publication Plan

Decision Resources Group companies include: